Paul Scheepers has been invited as contributing author to the flagship Report “Science for Disaster Risk Management 2020 - Acting today, Protecting Tomorrow”.Report “Science for Disaster Risk Management 2020 - Acting today, Protecting Tomorrow”.
This EU report is prepared by the Disaster Risk Management Knowledge Centre (DRMKC) at the Joint Research Centre, the scientific service of the European Commission. His contribution will address the hazards and related vulnerability that mostly threat human lives in the EU, either by death, injury or other health damage.
Paul Scheepers was invited based on several publications on the use of human biological monitoring in response to chemical incidents. His publications supported the decision of the federal government in Belgium to initiate a human biomonitoring study in the aftermath of the train crash in Wetteren. The use of biomarkers in the disaster risk management setting is considered an important innovative methodology that will support human health risk assessment during the aftermath of a disaster.
This authorship will complement his involvement as rapid risk assessment expert on chemical threats for the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) of DG Health and Food Safety that is mandated by the European Commission to provide within a short time-frame (36 hours) public health risk assessment in case of cross-border chemical threats in the European Union.
Related news items
Regional hospitals invest in joint research Four new projects have been granted29 October 2020
Four more research projects have been granted in the promotion fund of the Radboudumc and the regional hospitals.read more
Two studies show potential of trained immunity for the treatment of cancer Radboudumc makes Cell twice in one issue29 October 2020
Mihai Netea: "These studies show that stimulating trained immunity can have an important anti-cancer effect. In combination with current immunotherapy with 'checkpoint inhibitors', boosting trained immunity has the potential to significantly improve cancer treatment"read more
Research should facilitate discontinuation of antidepressants29 October 2020
How do you reduce the use of antidepressants safely and without major problems? That is a question that concerns many patients and physicians. Radboudumc and Amsterdam UMC in the Netherlands are going to investigate this with a ZonMw grant of 1.5 million euros.read more
Cum Laude PhD defense for Vincent Aengevaeren29 October 2020
We congratulate Vincent Aengevaeren! After defending his thesis entitled: ‘Potential Detrimental Effects of Exercise on the Heart’ on 28 October, Vincent attained his PhD degree with honors. Vincent had been appointed on a RIHS Junior Researcher grant.read more
Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation28 October 2020
A multidisciplinary team of RIMLS and Radboud University researchers published in Advanced Science that Polyisocyanide Hydrogels as a Tunable Platform for Mammary Gland Organoid Formation.read more